VICEBIO

Updated 221 days ago
Private Limited Company
  • Active - 11570257 (CH)
  • Age: 5 years
  • ID: 51187724/11
2ND FLOOR 168 SHOREDITCH HIGH STREET LONDON UNITED KINGDOM E1 6RA
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
• 72110 - Research and experimental development on biotechnology
The Vicebio team has extensive experience in the research & development of innovative vaccines and has contributed to the launch of several commercially valuable products using platform technologies... We are committed to developing highly innovative and effective vaccines to target life-threatening respiratory viral infectious diseases... We were founded to develop the patented Molecular Clamp technology invented at The University of Queensland, Australia and exclusively licensed to Vicebio by UniQuest, the commercialisation company of UQ. The Molecular Clamp technology stabilises viral glycoproteins in "prefusion" conformation, to deliver highly protective and ready-to-use fully liquid vaccines.
Also known as: VICEBIO LIMITED, Vicebio Ltd
Previous names: MV1 MEDICINES LIMITED
Registration numbers: 11570257 (CH)
Primary location: LONDON UNITED KINGDOM
  • 0
  • 0
Interest Score
2
HIT Score
0.67
CEO
Emmanuel Hanon
CTO
Jean Smal
General
in..@vicebio.com, in..@vicebio.com

UK Company Data

Company number
11570257		 Account category
SMALL		 Account ref. day
31		 Account ref. month
12
Accounts next due date
2024-09-30		 Accounts last made up date
2022-12-31		 Returns next due date
2019-10-12		 Returns last made up date
N/A
Num. mort. charges
2		 Num. mort. outstanding
1		 Num. mort. part. satisfied
0		 Num. mort. satisfied
1
Num. gen. partners
0		 Num. lim. partners
0
Domain
vicebio.com
Actual
vicebio.com
IP
35.214.97.45
Status
OK
Category
Company
0 comments Add a comment